StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

LivaNova cash

Cash and short-term investments held at the end of each period.

LivaNova's cash was $516.62M at Jun 30, 2026. For fiscal 2025 it was $635.55M, down 12.2% from the year before. Over ten years it grew 17.7% a year on average. The highest annual figure on record is $723.56M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$635.55M-12.2%
FY2024Dec 31, 2024$723.56M+171.5%
FY2023Dec 31, 2023$266.50M-48.3%
FY2022Dec 31, 2022$515.62M+147.9%
FY2021Dec 31, 2021$207.99M-17.7%
FY2020Dec 31, 2020$252.83M+313.5%
FY2019Dec 31, 2019$61.14M+29.5%
FY2018Dec 31, 2018$47.20M-49.6%
FY2017Dec 31, 2017$93.62M-24.6%
FY2015Apr 24, 2015$124.19M0.0%
FY2014Apr 25, 2014$124.19M+20.2%
FY2013Apr 26, 2013$103.30M+6.9%
FY2012Apr 27, 2012$96.66M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$516.62M-13.0%
Q1 FY2026CQ1 2026Mar 31, 2026$539.71M-26.9%
Q4 FY2025CQ4 2025Dec 31, 2025$635.55M-12.2%
Q3 FY2025CQ3 2025Sep 30, 2025$646.08M-3.1%
Q2 FY2025CQ2 2025Jun 30, 2025$593.64M-6.2%
Q1 FY2025CQ1 2025Mar 31, 2025$738.44M+19.9%
Q4 FY2024CQ4 2024Dec 31, 2024$723.56M+171.5%
Q3 FY2024CQ3 2024Sep 30, 2024$666.58M+25.1%
Q2 FY2024CQ2 2024Jun 30, 2024$633.12M+18.5%
Q1 FY2024CQ1 2024Mar 31, 2024$615.68M+17.7%
Q4 FY2023CQ4 2023Dec 31, 2023$266.50M-48.3%
Q3 FY2023CQ3 2023Sep 30, 2023$532.72M+5.2%
Q2 FY2023CQ2 2023Jun 30, 2023$534.36M+31.4%
Q1 FY2023CQ1 2023Mar 31, 2023$522.96M+18.2%
Q4 FY2022CQ4 2022Dec 31, 2022$515.62M+147.9%
Q3 FY2022CQ3 2022Sep 30, 2022$506.28M+178.4%
Q2 FY2022CQ2 2022Jun 30, 2022$406.77M+23.5%
Q1 FY2022CQ1 2022Mar 31, 2022$442.38M+75.2%
Q4 FY2021CQ4 2021Dec 31, 2021$207.99M-17.7%
Q3 FY2021CQ3 2021Sep 30, 2021$181.85M-20.2%
Q2 FY2021CQ2 2021Jun 30, 2021$329.39M+41.6%
Q1 FY2021CQ1 2021Mar 31, 2021$252.54M+100.7%
Q4 FY2020CQ4 2020Dec 31, 2020$252.83M+313.5%
Q3 FY2020CQ3 2020Sep 30, 2020$227.81M+202.5%
Q2 FY2020CQ2 2020Jun 30, 2020$232.55M+422.5%
Q1 FY2020CQ1 2020Mar 31, 2020$125.82M+147.8%
Q4 FY2019CQ4 2019Dec 31, 2019$61.14M+29.5%
Q3 FY2019CQ3 2019Sep 30, 2019$75.31M-5.8%
Q2 FY2019CQ2 2019Jun 30, 2019$44.51M-6.1%
Q1 FY2019CQ1 2019Mar 31, 2019$50.78M-21.8%
Q4 FY2018CQ4 2018Dec 31, 2018$47.20M-49.6%
Q3 FY2018CQ3 2018Sep 30, 2018$79.95M+22.7%
Q2 FY2018CQ2 2018Jun 30, 2018$47.38M+11.0%
Q1 FY2018CQ1 2018Mar 31, 2018$64.96M+3.6%
Q4 FY2017CQ4 2017Dec 31, 2017$93.62M-24.6%
Q3 FY2017CQ3 2017Sep 30, 2017$65.16M-43.9%
Q2 FY2017CQ2 2017Jun 30, 2017$42.69M–
Q1 FY2017CQ1 2017Mar 31, 2017$62.72M–
Q4 FY2015CQ1 2015Apr 24, 2015$124.19M–
Q3 FY2015CQ4 2014Jan 23, 2015$116.22M–

More LivaNova figures

See a number that looks wrong?